×
+ All Categories
Log in
English
Français
Español
Deutsch
Report -
WuXi Biologics 2017 Interim Results · 6 First Half 2017 Overview: Revenue Revenue grew 59.5% YoY, from RMB410.1 million to RMB654.0 million Revenue growth in the United States, China,
Name
Email
Select
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Message
Please pass captcha verification before submit form